Bengaluru-based Greenspace Herbs has formally launched its Quantum Ayurveda platform in the United States, backed by published clinical research, a new operational base in New Jersey, and an experienced U.S. leadership team tasked with bringing the approach into the mainstream.
For millions of Americans navigating supplement aisles crowded with bold but often unverified claims, the company says it is offering something rarely seen in the industry: evidence to support its approach.
According to Greenspace Herbs, the platform is designed to make plant-based ingredients more usable for the body, enabling them to work more efficiently at lower doses while delivering faster, measurable results.
The concept addresses a long-standing limitation in the supplement industry. Many traditional supplements require higher doses because the body absorbs only a small fraction of what is consumed. Greenspace says its technology is designed to improve that efficiency.
Clinical studies published in peer-reviewed scientific journals indicate that the company’s enhanced botanicals, including curcumin, ashwagandha, bacopa, and berberine, can produce measurable effects at roughly one-third of conventional dosing levels. The research also points to faster response timelines that consumers may notice sooner.
Reflecting on the approach, Shafiulla Hirehal Nuruddin, Founder & Managing Director of Greenspace Herbs, said, “Today’s wellness consumer is educated, demanding, and done with empty promises. They want to know: what does the science say, and will I feel the difference? Quantum Ayurveda was built specifically to answer both questions. We have done the clinical work. We have published the results. Now we are here in the U.S. to ensure that every consumer who chooses our platform experiences wellness that is real, measurable, and rooted in thousands of years of botanical knowledge — elevated by 21st-century science.”
Greenspace is now focusing its expansion on the United States, the world’s largest dietary supplement market, valued at more than $50 billion.
To lead the company’s U.S. expansion, Greenspace has appointed Gregory Arabatzis as Chief Business Officer for the United States. A two-decade veteran of the nutraceutical industry, Arabatzis is known for helping scale science-driven wellness brands into multimillion-dollar businesses.
“The U.S. market rewards clinically substantiated innovation. Quantum Ayurveda stands out because it is not theoretical — it is supported by published scientific data. Our focus now is structured commercialization, education, and partnership development,” said Gregory Arabatzis, Chief Business Officer, USA.
The company has also established a warehouse and operational office in New Jersey, signaling a long-term commitment to building its presence in the American market.
Greenspace is also planning to establish Quantum Technology Frequency Labs in the United States. These facilities are expected to support clinical collaborations, ingredient customization, and joint development programs with partners.
The company says the initiative reflects a long-term investment in the American wellness ecosystem rather than a short-term market push.